Benefits of high-dose intravenous immunoglobulin on mortality in patients with severe COVID-19: An updated systematic review and meta-analysis

BACKGROUND: The clinical benefits of high-dose intravenous immunoglobulin (IVIg) in treating COVID-19 remained controversial. METHODS: We systematically searched databases up to February 17, 2022, for studies examining the efficacy of IVIg compared to routine care. Meta-analyses were conducted using...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaosheng, Zhang, Yuelun, Lu, Lianfeng, Li, Xiaodi, Wu, Yuanni, Yang, Yang, Li, Taisheng, Cao, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900022/
https://www.ncbi.nlm.nih.gov/pubmed/36756131
http://dx.doi.org/10.3389/fimmu.2023.1116738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900022/
https://www.ncbi.nlm.nih.gov/pubmed/36756131
http://dx.doi.org/10.3389/fimmu.2023.1116738

Ejemplares similares